NASRIX is indicated as an adjunct to diet in the treatment of primary hypercholesterolemia (heterozygous familial and non-familial) hyperlipidemia or mixed hyperlipidemia, and the combination treatment is appropriate, as:
– Using simvastatin alone is inadequate.
– Patients previously treated with simvastatin and ezetimibe

This is only the preview. Please check here for the full indication.